Literature DB >> 10719661

[Tobacco use and smoking cessation in the psychiatric patient].

A Batra1.   

Abstract

Smoking is far more prevalent among psychiatric patients than with healthy individuals. Particularly patients with substance-related disorders and schizophrenia often are addicted smokers. This is of great importance, as heavy smoking is clearly accompanied by a higher morbidity and mortality. Up to now there is no convincing explanation for the high prevalence of smoking. Numerous studies point to the fact that smoking is practised as a form of self-medication by psychiatric patients. The influences on cerebral dopaminergic or cholinergic transmission or even psychopharmacological treatment may reinforce smoking behaviour. Efforts to reduce the frequency of smoking in case of psychiatric patients have mostly proved fruitless. Prevention strategies as well as smoking cessation therapies seldom achieve success due to the poor motivation. Besides that smoking cessation often is complicated due to the simultaneous psychopharmacological treatment. The latest investigations, however, confirm the efficacy of cessation strategies, also in case of schizophrenia, mood or substance related disorders. Intensive behavioural treatment strategies as well as high dose nicotine replacement achieve encouraging long-term abstinence rates. Nicotine replacement by patch, gum or nasal spray might be a kind of causal treatment, assuming biological mechanisms to be responsible for heavy smoking.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10719661     DOI: 10.1055/s-2000-11646

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  7 in total

Review 1.  [Treatment of tobacco dependence: a responsibility of psychiatry and addiction medicine].

Authors:  A Batra; H M Friederich; U Lutz
Journal:  Nervenarzt       Date:  2009-09       Impact factor: 1.214

2.  Overnight deprivation from smoking disrupts amygdala responses to fear.

Authors:  Oezguer A Onur; Alexandra Patin; Yoan Mihov; Boris Buecher; Birgit Stoffel-Wagner; Thomas E Schlaepfer; Henrik Walter; Wolfgang Maier; René Hurlemann
Journal:  Hum Brain Mapp       Date:  2011-05-26       Impact factor: 5.038

3.  [Consequences of hospitalisations on smoking behaviour in psychiatric and somatic inpatients].

Authors:  Christoph Silberbauer; Edmund Grunbacher
Journal:  Neuropsychiatr       Date:  2014

Review 4.  Treatment of tobacco dependence.

Authors:  Anil Batra
Journal:  Dtsch Arztebl Int       Date:  2011-08-19       Impact factor: 5.594

5.  [Acceptance of smoke-free policy in a psychiatric department by in-patients and staff].

Authors:  Friederike D Wernz; Hubertus M Friederich; Gerhard Buchkremer; Anil Batra
Journal:  Wien Med Wochenschr       Date:  2009

6.  European network for promoting the physical health of residents in psychiatric and social care facilities (HELPS): background, aims and methods.

Authors:  Prisca Weiser; Thomas Becker; Carolin Losert; Köksal Alptekin; Loretta Berti; Lorenzo Burti; Alexandra Burton; Mojca Dernovsek; Eva Dragomirecka; Marion Freidl; Fabian Friedrich; Aneta Genova; Arunas Germanavicius; Ulaş Halis; John Henderson; Peter Hjorth; Taavi Lai; Jens Ivar Larsen; Katarzyna Lech; Ramona Lucas; Roxana Marginean; David McDaid; Maya Mladenova; Povl Munk-Jørgensen; Alexandru Paziuc; Petronela Paziuc; Stefan Priebe; Katarzyna Prot-Klinger; Johannes Wancata; Reinhold Kilian
Journal:  BMC Public Health       Date:  2009-08-28       Impact factor: 3.295

Review 7.  Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs-Influence of Smoking Behavior and Inflammation on Pharmacokinetics.

Authors:  Nicole Moschny; Gudrun Hefner; Renate Grohmann; Gabriel Eckermann; Hannah B Maier; Johanna Seifert; Johannes Heck; Flverly Francis; Stefan Bleich; Sermin Toto; Catharina Meissner
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.